Avastin helps women who are suffering from ovarian cancer

October 12th, 2010 - 8:09 pm ICT by Aishwarya Bhatt  

New York, Oct 12 (THAINDIAN NEWS) The drug Avastin has been found to help women with ovarian cancer live longer without increasing the severity of their condition.

However the drug’s positive effect lasts for a maximum of 12 months and the effect diminishes afterwards.

The finding was as a result of a research that was announced on Monday. According to the report of the research, the drug extends the excepted lifespan of the patient by 1.5 months without their disease getting worse.

The search for a drug for ovarian cancer drug has not yielded any major breakthrough but scientists believe the drug can provide a leap forward in managing ovarian cancer.

However Avastin is not the only option that is being considered for the management of the disease. Other drugs including Amgen’s AMG 386 have all shown considerable signs in tests.

The drug, which is manufactured by Roche, is currently used in the management of breast, bowel, lung and other forms of cancer. In 2009, the drug grossed some $6 billion in sales throughout the world.

Roche’s bid to expand the drug’s benefits to other forms of cancer hit a snag this year as the drug failed trial runs for prostate and gastric cancer. The drug’s effectiveness in breast cancer management has also been doubted.

Related Stories

Tags: , , , , , , , , , , , , , , , , , ,

Posted in Health |